Morimoto T, Nakazawa T, Maeoka R, Nakagawa I, Tsujimura T, Matsuda R
Int J Mol Sci. 2023; 24(3).
PMID: 36768432
PMC: 9916747.
DOI: 10.3390/ijms24032111.
Auer I, Ziemer E, Sommer H
Clin Exp Immunol. 1980; 42(1):41-9.
PMID: 7460390
PMC: 1537072.
Zaunders J, Werkmeister J, McCarthy W, Hersey P
Br J Cancer. 1981; 43(1):5-12.
PMID: 7459237
PMC: 2010488.
DOI: 10.1038/bjc.1981.2.
Knight R, Fitzharris P
Br J Cancer. 1980; 42(2):243-51.
PMID: 6968571
PMC: 2010378.
DOI: 10.1038/bjc.1980.223.
Pullen S, Hersey P
Clin Exp Immunol. 1980; 39(2):403-10.
PMID: 6966993
PMC: 1538051.
The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
Richter M, Banerjee D, SKLAR S
Immunology. 1981; 44(1):109-18.
PMID: 6944271
PMC: 1555109.
Phenotype of cytotoxic effector cells infiltrating a transplanted, chemically induced rat sarcoma.
Ferry B, Flannery G, Robins R, Lawry J, Baldwin R
Immunology. 1984; 53(2):243-50.
PMID: 6490084
PMC: 1454825.
The origin of human NK cells. An ontogenic model derived from studies in patients with immunodeficiencies.
Peter H
Blut. 1983; 46(5):239-48.
PMID: 6404329
DOI: 10.1007/BF00319864.
Deficient spontaneous cell-mediated cytotoxicity and lectin-induced cellular cytotoxicity by peripheral blood mononuclear cells from Thai adults naturally infected with malaria.
Gilbreath M, Pavanand K, Macdermott R, Phisphumvithi P, Permpanich B, Wimonwattrawatee T
J Clin Microbiol. 1983; 17(2):296-304.
PMID: 6339549
PMC: 272625.
DOI: 10.1128/jcm.17.2.296-304.1983.
A cloned human T cell line cytotoxic for autologous and allogeneic B lymphoma cells.
Yssel H, Spits H, De Vries J
J Exp Med. 1984; 160(1):239-54.
PMID: 6204000
PMC: 2187414.
DOI: 10.1084/jem.160.1.239.
Alloreactive cytotoxicity of interferon-triggered human lymphocytes detected with tumor biopsy targets.
Vanky F, Klein E
Immunogenetics. 1982; 15(1):31-9.
PMID: 6177627
DOI: 10.1007/BF00375500.
Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
Grimm E, Mazumder A, Zhang H, Rosenberg S
J Exp Med. 1982; 155(6):1823-41.
PMID: 6176669
PMC: 2186695.
DOI: 10.1084/jem.155.6.1823.
Target selectivity of interferon-induced human killer lymphocytes related to their Fc receptor expression.
Masucci M, Masucci G, Klein E, Berthold W
Proc Natl Acad Sci U S A. 1980; 77(6):3620-4.
PMID: 6158052
PMC: 349669.
DOI: 10.1073/pnas.77.6.3620.
Immunological consequence of renal transplantation and immunosuppression. I. Alterations in human natural killer-cell activity.
Waltzer W, Bachvaroff R, Arnold A, Anaise D, RAPAPORT F
J Clin Immunol. 1985; 5(2):78-83.
PMID: 3886685
DOI: 10.1007/BF00915004.
Augmentation of generation of human allospecific cytotoxic T lymphocyte by PPD in in vitro sensitization culture.
Ohno R, Kodera Y, Yamada H
Cancer Immunol Immunother. 1985; 19(1):46-52.
PMID: 3156667
PMC: 11039268.
DOI: 10.1007/BF00199311.
Cytotoxic activity of human lymphocyte plasma membranes.
FERLUGA J, Friou G, Allison A
Clin Exp Immunol. 1976; 25(2):347-51.
PMID: 821684
PMC: 1541352.
Relationship of cell-mediated cytotoxicity against melanoma cells to prognosis in melanoma patients.
Hershey P, Edwards A, Milton G, McCarthy W
Br J Cancer. 1978; 37(4):505-13.
PMID: 646923
PMC: 2009547.
DOI: 10.1038/bjc.1978.78.
Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma.
Thatcher N, Palmer M, Gasiunas N, Crowther D
Br J Cancer. 1977; 36(6):751-62.
PMID: 597473
PMC: 2025560.
DOI: 10.1038/bjc.1977.258.
Identification of lymphocyte subpopulations in E-RFC-enriched and E-RFC-depleted cell fractions of fresh and cryopreserved lymphocytes.
Bolhuis R, SCHUIT H
Clin Exp Immunol. 1979; 35(2):317-23.
PMID: 312177
PMC: 1537634.
Relationship of natural killer-cell activity to rhesus antigens in man.
Hersey P, Edwards A, Trilivas C, Shaw H, Milton G
Br J Cancer. 1979; 39(3):234-40.
PMID: 111695
PMC: 2009882.
DOI: 10.1038/bjc.1979.46.